This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

COL RICHARD M. LAMPE, MD, MC
USA Department of Pediatrics

COL MICHAEL R. WEIR, MD, MC
USA Department of Clinical Investigation William Beaumont Army Medical Center El Paso, TX 79920

Am J Dis Child. 1985;139(9):858.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—Drs Wilkins and Wehrle have identified important differences between their study and ours. Their study, published in 1979, served as the impetus for us to obtain sera on children who had received rubeola vaccine before 1 year of age and were about to receive the MMR vaccine at 15 months of age. We did not obtain sera later than 52 days after MMR vaccination; therefore, we agree that our results should not be directly compared with their results indicating that 51% of 37 infants identified as vaccine failures had no detectable HI antibody by eight months after revaccination.

We would also like to address three points raised by Wilkins and Wehrle. First, some children in the vaccinated group could have experienced wild measles virus infection, although we had no history of this at the time of MMR vaccination. Second, we sought to obtain acute and convalescent sera from . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?